Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Charity calls for anti-depressant prescription review


Campaigners have called for a review into the way anti-depressants are prescribed after a study showed that a third of women have taken the drugs at some point in their lives.

Platform 51 said the high proportion of women who are given anti-depressants, and the lack of regular treatment reviews, posed “worrying questions” about the provision of such drugs.

A report released by the charity shows that 24% of women who are currently taking anti-depressants have been using them for 10 years or more, while 48% have taken them for at least five years.

The findings also showed that 24% of women who are on anti-depressants have waited at least a year for a review of their treatment, while 57% were not offered any alternatives to the drugs when they were prescribed.

The findings are based on a survey of more than 2,000 adults in England and Wales.

Platform 51’s director of policy, campaigns and communications Rebecca Gill, said: “The current NICE guidelines are not being followed: women want more checks to make sure the medication use is right for them and they want more choice when it comes to receiving treatment.”

Are you a nurse tweeter? Follow us on @NursingTimes


Readers' comments (2)

  • Reference and link to report please.

    Unsuitable or offensive? Report this comment

  • Anonymous | 6-Jul-2011 11:08 pm

    second that

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.